http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002518354-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70596 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-06 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-06 |
| filingDate | 1999-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002518354-A |
| titleOfInvention | Glycosulfate peptides, their synthesis and use |
| abstract | (57) Abstract: A new class of synthetic glycosulfate peptides (GSPs) having one or more tyrosine sulfate residues and glycans attached to a peptide, wherein the glycans include a sialyl Lewis X group or a sialyl Lewis a group Is preferred. In a preferred embodiment, the GSP has an O-glycan comprising a β1,6 linkage to GalNAc. The present invention further contemplates methods for synthesizing these GSPs in vitro without cells and for use in vivo as potent anti-inflammatory antithrombotic agents or metastasis inhibitors. The present invention also contemplates a method for synthesizing oligosaccharides by cleaving glycans from GSPs. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007524693-A |
| priorityDate | 1998-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 537.